Diazepam Injection USP 10mg/2mL — Class II drug recall D-1359-2016
Terminated recall by Hospira Inc., reported 2016-07-20, distributed nationwide. Crystallization: Product contains particulate identified to be crystallized active ingredient.
| Recall number | D-1359-2016 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Hospira Inc., Lake Forest, IL, United States |
| Recall initiated | 2016-06-23 |
| Classified | 2016-07-12 |
| Reported by FDA | 2016-07-20 |
| Terminated | 2018-08-31 |
| Distributed | Nationwide (US) |
| Quantity | 373,850 tubes |
| Reason classes | specification failure |
| NDC | 00409-1273, 00409-1273-03, 00409-1273-32 |
| Lot numbers | 52610LL, 57660LL |
| Expiration dates | 2016-10-01, 2017-03-01 |
Product
Diazepam Injection USP 10mg/2mL (5 mg/mL, 2 mL), Rx only, Hospira Inc. Lake Forest, IL 60045, NDC 0409-1273-32
Reason for recall
Crystallization: Product contains particulate identified to be crystallized active ingredient.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1359-2016. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.